Skip to content
Episode 62: Drug Adherence and Persistence episode artwork

Sep 4, 2026 10 min

Episode 62: Drug Adherence and Persistence

from QCast: Data-Driven Dialogue in Drug Development Hosted by Quanticate

Drug adherence and persistence measures built from claims or EHR databases depend as much on study definitions as recorded treatment events. In this QCast episode, co-hosts Jullia and Tom explain how adherence differs from persistence, what prescribing and dispensing data can and cannot show, and how MPR, PDC, treatment-gap rules and thresholds shape the findings. Key Takeaways Adherence describes how closely medicine use follows the agreed regimen, while persistence measures how long treatment continues before discontinuation. Claims and EHR data provide useful evidence on prescriptions, dispensing and treatment changes, but neither confirms that a patient took the medicine as intended. MPR, PDC and persistence estimates depend on decisions about follow-up, days’ supply, permissible gaps, dose changes, switching and censoring. 🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & Management Biostatistics & Statistical Consultancy Statistical Programming & PK/PD Analysis Medical Writing & Pharmacovigilance Regulatory & Submission Support AI & Automation Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode details come from the podcast's RSS feed.

Embed this episode

Drug adherence and persistence measures built from claims or EHR databases depend as much on study definitions as recorded treatment events. In this QCast episode, co-hosts Jullia and Tom explain how adherence differs from persistence, what prescribing and dispensing data can and cannot show, and how MPR, PDC, treatment-gap rules and thresholds shape the findings. Key Takeaways Adherence describes how closely medicine use follows the agreed regimen, while persistence measures how long treatme...

Ready to play

Episode 62: Drug Adherence and Persistence

0:00 10:39

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of QCast: Data-Driven Dialogue in Drug Development?

This episode is 10 minutes long.

When was this QCast: Data-Driven Dialogue in Drug Development episode published?

This episode was published on September 4, 2026.

Can I download this QCast: Data-Driven Dialogue in Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.